Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 29/54
Thad
Cochran
U.S. Senate · R-MS
Taken from pharma & insurers
$29,150
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 29/54
Pharma & Health$29,150
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 29 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$29,150
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
Beyond the campaign account, a leadership PAC under Cochran's control (The Senate Victory Fund PAC) took $88,500 from banks, card lenders, drug makers and insurers.
Source: FEC; The Senate Victory Fund PAC
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
★ Hall of Shame
Cochran voted with the money in more than one set:
Don't recognize a logo? Here's the key.
Pharma & Health$29,150
Johnson & Johnson$18,300
PhRMA$5,500
Amgen$2,600
Merck$1,750
Bristol Myers Squibb$1,000